See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 3, 2007

Vascular Diseases Renal Cell Carcinoma Malignant Melanoma

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Vascular Diseases

People with edema are being sought to participate in this research study. You may be eligible if you are older than 18 and have had symptoms of HAE or AAE. Additional criteria may apply.

The research site is in New York, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat302.html.

-----

Renal Cell Carcinoma

This clinical trial will evaluate the safety and efficacy of a study drug versus non-medicinal placebo in people with clear renal cell carcinoma and a high risk of recurrence. To qualify, you must be at least 18 and have prior nephrectomy (removal of all or a portion of the kidney) of primary kidney cell cancer with documented clear cell cancer. Other criteria apply.

The research site is in Manhasset, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat363.html.

-----

Malignant Melanoma

This study will compare an investigational compound with existing therapies for advanced melanoma. Researchers are looking for people with surgically incurable melanoma, either Stage IIIC with N3 status for regional lymph nodes and in-transit or satellite lesions or Stage IV, among other criteria.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat196.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.